Ann: Submits New Information to FDA IND File for SR-aGVHD, page-308

It's really, hard to get a word in around here, but the time I've read all of the posts, most of which are personal arguments totally unrelated to the company and should be reported as if topic, it's way past bedtime and I can't string a sentence together.
It seems most here are of the opinion that MSB failed to resubmit the BLA by the end of the quarter, and you all had me convinced of that too. However, reading the announcements you provided above I am no longer of this opinion, I think everyone on here, both bulls and bears, misinterpreted what was promised. If I leave out a few words from the above announcements, they state "Mesoblast will provide.. .new data... required for the BLA resubmission" and "Mesoblast will provide.. .new data... required for the BLA resubmission this quarter", which can be interpreted as "Mesoblast will provide new data this quarter".
So perhaps they have done as promised.